- March 01, 2022
- Taiho Pharmaceutical Co., Ltd.
Taiho Pharmaceutical Launches Harncare Bearberry Tablets ー Helping to Improve the Discomfort When Urinating and Sensation of Residual Urine
Taiho Pharmaceutical Co., Ltd. announced today, it has launched Harncare Bearberry Tablets in pharmacies and drugstores throughout Japan. Harncare Bearberry Tablets, a second-class OTC drug, is an herbal remedy for discomfort when urinating and the sensation of residual urine.
Infection of the lower urinary tract are one of the causes of symptoms such as sensation of residual urine and discomfort or a strange feeling when urinating. These subjective symptoms are overwhelmingly experienced by women, and survey results indicate that the frequency is one in three women.1
Harncare Bearberry Tablets is the first tablet formulation in Japan of the single crude drug, bearberry. It disinfects the urinary tract of those who have discomfort or a sensation of residual urine, and improves those symptoms. It contains the maximum amount of bearberry as an active ingredient in an OTC drug (within the standard for approval to manufacture and sell general-use crude drugs2) as an approach to improve the discomfort when urinating and the sensation of residual urine that tends to occur in repetition.
As a pioneer in OTC drugs for urinary problems, Taiho Pharmaceutical launched Harncare Drink,3 the first OTC drug indicated for mild incontinence at the time of its launch in 2001. The company has now launched Harncare Bearberry Tablets, the first tablet formulation in Japan of the single crude drug, bearberry.
Taiho Pharmaceutical will continue to help people deal with various urinary problems.
- 2018 consumer survey data; independent survey
- The approval standard is the range of pharmaceuticals specified by the Japanese Ministry of Health, Labour and Welfare to improve the efficiency of approval work.
- Learn more about the Harncare series here:Harncare Series | Product Information | Taiho Pharmaceutical Co., Ltd.
-
-
- 84tablets
-
-
-
- 48tablets
-
Product Features
- Contains the maximum amount of bearberry as an active ingredient in an OTC drug (within the standard for approval to manufacture and sell general-use crude drugs２)
- The first tablet formulation in Japan of the single crude drug, bearberry
- Improves discomfort when urinating and the sensation of residual urine by disinfecting the urinary tract
Product Overview
|
Brand name |
Harncare Bearberry Tablets |
|
Risk categories |
Second-class OTC drug |
|
Ingredients/amount |
Dried bearberry extract: 1,875 mg (equivalent to 15 g of bearberry) |
|
Dosage and administration |
Take the following amount with cold or warm water before or between meals. |
|
Indication |
Persons with a sensation of residual urine (feeling that one’s bladder has not been completely emptied) and discomfort when urinating |
|
Suggested retail price |
48 tablets: JPY 1,760 yen (JPY 1,600 excluding tax) |
|
Launch date |
March 1, 2022 |
|
Manufacturer |
Matsuura Yakugyo Co., Ltd. |
|
Distributor |
Taiho Pharmaceutical Co., Ltd. |
Information in this news release was current as of the original release date.
Taiho Pharmaceutical's news releases are intended to provide information to the media. It may contain information about ethical drugs or products under development, however information contained in the news releases are not intended to constitute promotion, advertisement, or medical advice.